bioRxivCell BiologyPreprint
Adaptation to ex vivo culture drives human haematopoietic stem cell loss of repopulation capacity in a cell cycle independent manner
C. S. Johnson, K. Sham, S. Belluschi, X. Wang, W. Lau, K. B. Kaufmann, G. Krivdova, E. F. Calderbank, N. Mende, J. McLeod, G. Mantica, M. J. Williams, C. Grey-Wilson, M. Drakopoulos, S. Sinha, E. Diamanti, C. Basford, A. R. Green, N. K. Wilson, S. J. Howe, J. E. Dick, B. Gottgens, N. Francis, E. Laurenti
Abstract
Loss of long-term haematopoietic stem cell function (LT-HSC) hampers the success of ex vivo HSC gene therapy and expansion procedures, but the kinetics and the mechanisms by which this occurs remain incompletely characterized. Here through time-resolved scRNA-Seq, matched in vivo functional analysis and the use of a reversible in vitro system of early G1 arrest, we define the sequence of transcriptional and functional events occurring during the first ex vivo division of human LT-HSCs. We demonstrate that contrary to current assumptions, loss of long-term repopulation capacity during culture is independent of cell cycle progression. Instead it is a rapid event that follows an early period of adaptation to culture, characterised by transient gene expression dynamics and constrained global variability in gene expression. Cell cycle progression however contributes to the establishment of differentiation programmes in culture. Our data have important implications for improving HSC gene therapy and expansion protocols.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: trajectory inference
- research focus: differential expression
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Human Mobilized Peripheral Blood for Gene Therapy Applications
Erika Zonari, Matteo Maria Naldini, … Bernhard Gentner·Molecular TherapyPeer-reviewed·May 26, 2026
- Ex vivo Expansion Potential of Murine Hematopoietic Stem Cells: A Rare Property Only Partially Predicted by Phenotype
Q. Zhang, R. Olofzon, … D. Bryder·bioRxiv·Jun 20, 2022
- Spatiotemporal Proteome Remodeling Directs Human Hematopoietic Stem Cells via a Metabolic-Cytoskeletal Axis
Zahra Taghadomi Masoumi, Navin Shirodkar, … William E. Grey·bioRxiv·Jun 10, 2026
- Expansion of human hematopoietic stem cells by inhibiting translation
C. Li, H. Shin, … P. S. Klein·bioRxiv·Nov 28, 2023
- Optimized cell culture conditions promote ex-vivo manipulation and expansion of primitive hematopoietic stem cells for therapeutic gene editing.
R. Rai, W. Vetharoy, … A. Cavazza·bioRxiv·Jan 11, 2022
- Human Haematopoietic Stem Cells released into circulation following mobilization express multiple G0-associated quiescence markers
Jos Domen, Rahul Sinha, … Irving L. Weissman·bioRxiv·Jun 19, 2026